Pediatric Drugs SCIE

国际简称：PEDIATR DRUGS 参考译名：儿科药物

主要研究方向：PEDIATRICS-PHARMACOLOGY & PHARMACY 非预警期刊审稿周期： 12周，或约稿

《儿科药物》(Pediatric Drugs)是一本由Springer International Publishing出版的以PEDIATRICS-PHARMACOLOGY & PHARMACY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q1 JCR分区
52 年发文量
3.4 IF影响因子
未开放 是否OA
55 H-index
1999 创刊年份
6 issues per year 出版周期
English 出版语言

Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of review and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents. The Journal includes:

-overviews of contentious or emerging issues.

-comprehensive narrative reviews of topics relating to the effective and safe management of drug therapy through all stages of pediatric development.

-practical reviews covering optimum drug management of specific clinical situations.

-systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

-Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in the pediatric population.

-original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pediatric Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

[ 查看全部 ]

投稿咨询加急咨询

Pediatric Drugs期刊信息

ISSN：1174-5878
出版语言：English
是否OA：未开放
E-ISSN：1179-2019
出版地区：NEW ZEALAND
是否预警：否
出版商：Springer International Publishing
出版周期：6 issues per year
创刊时间：1999
开源占比：0.2356
Gold OA文章占比：29.27%
OA被引用占比：0.2235...
出版国人文章占比：0.02
出版撤稿占比：0
研究类文章占比：44.23%

Pediatric Drugs CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

7.2

1.017

1.263

学科类别	分区	排名	百分位
大类：Medicine 小类：Pediatrics, Perinatology and Child Health	Q1	27 / 330	91%
大类：Medicine 小类：Pharmacology (medical)	Q1	50 / 272	81%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Pediatric Drugs中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PEDIATRICS 儿科 PHARMACOLOGY & PHARMACY 药学	2区 3区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	PEDIATRICS 儿科 PHARMACOLOGY & PHARMACY 药学	2区 2区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PEDIATRICS 儿科 PHARMACOLOGY & PHARMACY 药学	3区 3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PEDIATRICS 儿科 PHARMACOLOGY & PHARMACY 药学	3区 4区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PEDIATRICS 儿科 PHARMACOLOGY & PHARMACY 药学	3区 3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PEDIATRICS 儿科 PHARMACOLOGY & PHARMACY 药学	3区 3区

Pediatric Drugs JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：PEDIATRICS	SCIE	Q1	19 / 186	90.1%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	105 / 354	70.5%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：PEDIATRICS	SCIE	Q1	39 / 186	79.3%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	78 / 354	78.11%

Pediatric Drugs历年数据统计

影响因子

中科院分区

Pediatric Drugs中国学者发文选摘

1、Trends in Adverse Drug Reactions Among Children: Evidence from Jiangsu Province of China, 2010-2019
Author: Xue, Hui; Li, Ming; Fan, Lijun; Du, Wei; Zou, Jianjun

Journal: PEDIATRIC DRUGS. 2023; Vol. 25, Issue 1, pp. 97-114. DOI: 10.1007/s40272-022-00539-6
2、Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives
Author: Zhao, Jinxia; Bian, Jialu; Zhao, Yinyu; Li, Yuanyuan; Liu, Boyu; Hao, Xu; He, Shiyu; Huang, Lin

Journal: PEDIATRIC DRUGS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40272-023-00560-3
3、Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis
Author: Noor B. Almandil, Ying Liu, Macey L. Murray, Frank M. C. Besag, Katherine J. Aitchison, Ian C. K. Wong

Journal: PEDIATRIC DRUGS, 2013, Vol.15, 139-150, DOI:10.1007/s40272-013-0016-6
4、The Role of Chemotherapy for Metastatic, Relapsed and Refractory Osteosarcoma
Author: Xin Xiao, Wei Wang, Zhen Wang

Journal: PEDIATRIC DRUGS, 2014, Vol.16, 503-512, DOI:10.1007/s40272-014-0095-z
5、Alternating Acetaminophen and Ibuprofen versus Monotherapies in Improvements of Distress and Reducing Refractory Fever in Febrile Children: A Randomized Controlled Trial
Author: Shuanghong Luo, Mengdong Ran, Qiuhong Luo, Min Shu, Qin Guo, Yu Zhu, Xiaoping Xie, Chongfan Zhang, Chaomin Wan

Journal: PEDIATRIC DRUGS, 2017, Vol.19, 479-486, DOI:10.1007/s40272-017-0237-1
6、Effectiveness and Safety of Different Once-Daily Doses of Adrenocorticotropic Hormone for Infantile Spasms
Author: Jinghua Yin, Qianjin Lu, Fei Yin, Ying Wang, Fang He, Liwen Wu, Lifen Yang, Xiaolu Deng, Chen Chen, Jing Peng

Journal: PEDIATRIC DRUGS, 2017, Vol.19, 357-365, DOI:10.1007/s40272-017-0225-5
7、Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children
Author: Yuwen Wang, Yi Xu, Runmei Zou, Lijia Wu, Ping Liu, Hong Yang, Zhenwu Xie, Cheng Wang

Journal: PEDIATRIC DRUGS, 2018, Vol.20, 285-290, DOI:10.1007/s40272-018-0284-2
8、Method Development for Clinical Comprehensive Evaluation of Pediatric Drugs Based on Multi-Criteria Decision Analysis: Application to Inhaled Corticosteroids for Children with Asthma
Author: Yuncui Yu, Lulu Jia, Yao Meng, Lihua Hu, Yiwei Liu, Xiaolu Nie, Meng Zhang, Xuan Zhang, Sheng Han, Xiaoxia Peng, Xiaoling Wang

Journal: PEDIATRIC DRUGS, 2017, Vol.20, 195-204, DOI:10.1007/s40272-017-0278-5